Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...
A group of pro-cannabis entities scheduled to present in the forthcoming cannabis rescheduling hearing have filed a new ...
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in ...
Despite legalization disappointments from 2024, the cannabis industry is far from standing still as the calendar changes over ...
A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...